Sanara Medtech Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.00x

Sanara Medtech Inc capital reinvestment ratio. Sanara Medtech Inc (SMTI) has a Capital Reinvestment Ratio of 0.00x as of June 2026, meaning it reinvests 0% of its operating cash flow ($2.04 Million) in capital expenditures ($5.28K). Check Sanara Medtech Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$2.04 Million
USD

Capital Expenditures

$5.28K
USD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Sanara Medtech Inc (2016–2025)

Capital reinvestment ratio of Sanara Medtech Inc from 2016 to 2025. This chart tracks Sanara Medtech Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Sanara Medtech Inc net asset momentum to track the company's year-over-year net asset growth rate.

Sanara Medtech Inc Capital Reinvestment Ratio by Year (2016–2025)

Sanara Medtech Inc capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Sanara Medtech Inc cash conversion from operations.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.68x $6.79 Million $4.63 Million ▲ +2127.0%
2018 0.03x $277.14K $8.48K ▲ +313.5%
2016 0.01x $409.25K $3.03K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow